<rss version="2.0" xmlns:fo="http://www.w3.org/1999/XSL/Format"><channel><title>Incirculation Blog Feed</title><link>http://www.incirculation.net/52694_0.aspx</link><description>Blog</description><language>en-us</language><pubDate></pubDate><lastBuildDate></lastBuildDate><docs></docs><generator></generator><managingEditor></managingEditor><webMaster></webMaster><item><title>HIV and the heart: A hidden opportunity</title><description>HIV-related heart disease is common but frequently overlooked. Nick Boon, from the University of Edinburgh, UK, discusses the cardiovascular problems associated with HIV/AIDS.</description><pubDate>2008-04-14</pubDate><link>http://www.incirculation.net/52693_96343.aspx</link></item><item><title>Back to the future: reflections on the Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure (COACH) trial</title><description>The final results of the COACH study were surprising. However, in their Key Opinion article, Tiny Jaarsma and Dirk J van Veldhuisen discuss the reasons why these results shouldn't lead us to abandon the concept of disease management programs for heart failure.</description><pubDate>2008-02-15</pubDate><link>http://www.incirculation.net/52693_95048.aspx</link></item><item><title>New European Society of Cardiology joint guidelines for the prevention of cardiovascular disease - for better or worse?</title><description>Leif Erhardt, Professor of Cardiology at Lund University, Sweden, discusses the impact of the recently released guidelines for the prevention of cardiovascular disease.</description><pubDate>2008-02-12</pubDate><link>http://www.incirculation.net/52693_94943.aspx</link></item><item><title>Pharmacogenetic control of warfarin dosage — the COUMA-GEN trial</title><description>Jeffrey Anderson of the IMC, Salt Lake City, Utah discusses the results of the COUMA-GEN trial, which asked whether a genotype-driven algorithm for warfarin dosing could be more successful in terms of therapeutic efficiency, efficacy and safety in comparison with standard or empirical dosing.</description><pubDate>2008-01-18</pubDate><link>http://www.incirculation.net/52693_94402.aspx</link></item><item><title>Nurse-led clinics in cardiology</title><description>Nurse-led clinics in cardiology are growing in number and scope. David R Thompson, of the Department of Health Sciences and Department of Cardiovascular Sciences, University of Leicester, UK, discusses the effectiveness of these facilities, but argues that they need support and integration with appropriate structures and systems to fulfil their potential.</description><pubDate>2007-12-12</pubDate><link>http://www.incirculation.net/52693_93708.aspx</link></item><item><title>Hormones and the heart: Are we any closer to agreement?</title><description>Helen Roberts, of the Department of Obstetrics and Gynaecology, University of Auckland, New Zealand, discusses differing interpretations of the WHI and WISDOM trials and their implications on treatment strategies.</description><pubDate>2007-10-30</pubDate><link>http://www.incirculation.net/52693_92751.aspx</link></item><item><title>The use of glitazones in type 2 diabetes</title><description>Miles Fisher, of the Glasgow Royal Infirmary, Glasgow, UK, discusses the outcomes of the PROactive, DREAM and ADOPT trials and provides an update from the ongoing RECORD trial.</description><pubDate>2007-09-28</pubDate><link>http://www.incirculation.net/52693_91664.aspx</link></item><item><title>Genetics in Cardiology – Progress and Promise</title><description>Steve E Humphries, of the Royal Free and UCL Medical School, London, UK, talks about how our increased understanding of genetics may translate into clinical practice in the field of cardiology.</description><pubDate>2007-07-30</pubDate><link>http://www.incirculation.net/52693_90012.aspx</link></item><item><title>Primary prevention of atherosclerosis in a low risk population: The METEOR study</title><description>The results of the recent METEOR study were announced earlier this year at the ACC.07, held in New Orleans, USA. Raphael Duivenvoorden and Eric de Groot, of the University of Amsterdam, The Netherlands, discuss these results in this Key Opinion.</description><pubDate>2007-07-23</pubDate><link>http://www.incirculation.net/52693_89828.aspx</link></item><item><title>Three year follow-up from the ICTUS trial: Early intervention or selective-based treatment for coronary heart disease?</title><description>Here, Christopher Cannon, of the TIMI Study Group, talks about the three-year follow-up for the Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) study.
</description><pubDate>2007-06-20</pubDate><link>http://www.incirculation.net/52693_88896.aspx</link></item><item><title>FUSION II and EVEREST: Fresh insights into acute heart failure therapy</title><description>Sidney Goldstein, of the Case Western Reserve University School of Medicine, Cleveland, OH, USA, examines the outcomes of the FUSION and EVEREST in the context of the current interest in more effective treatment and prevention of acute heart failure. 
</description><pubDate>2007-06-20</pubDate><link>http://www.incirculation.net/52693_88900.aspx</link></item><item><title>Was COURAGE a brave effort?</title><description>At the recent American College of Cardiology (ACC) 2007 meeting, held in New Orleans, LA, US, William Boden presented the results of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE). In this Key Opinion, Michel Bertrand, Emeritus Professor of Cardiology, University of Lille, France, asks whether the COURAGE results told us anything new in the field of coronary artery disease management.</description><pubDate>2007-06-01</pubDate><link>http://www.incirculation.net/52693_88373.aspx</link></item><item><title>Using microvolt T-wave alternans to improve the prevention of sudden cardiac death: as easy as ABCD?</title><description>Here, Lars Eckardt and Günter Breithardt, of the University of Münster, Germany, give their opinions on the first results of the Alternans Before Cardioverter Defibrillator (ABCD) trial, presented at the AHA 2006 meeting in Chicago, IL, USA. This trial evaluated the efficacy of microvolt T-wave alternans (MTWA) in targeting ICD therapy to patients at risk from sudden cardiac death.
</description><pubDate>2007-05-02</pubDate><link>http://www.incirculation.net/52693_87580.aspx</link></item><item><title>The importance of smoking bans in smoking prevention</title><description>July 2007 will see the UK join Ireland, Italy, France, and many states and cities in the USA in the implementation of public smoking bans. In this editorial, David Simpson, Director of the International Agency on Tobacco and Health, looks at the importance of smoking bans in smoking prevention.
</description><pubDate>2007-04-27</pubDate><link>http://www.incirculation.net/52693_87466.aspx</link></item><item><title>Benefits of B-type natriuretic peptide testing in heart failure</title><description>The use of B-type natriuretic peptides (BNP) for diagnosing heart failure has been an exciting development, although the adoption into clinical practice has been slow. Here, Dr. Kevin Goode, Dr. Milos Kubanek, and Professor John GF Cleland, from Castle Hill Hospital, Kingston-upon-Hull, UK, discuss the roles and limitations of BNP measurement as a diagnostic tool.</description><pubDate>2007-04-26</pubDate><link>http://www.incirculation.net/52693_87408.aspx</link></item><item><title>Closure of patent foramen ovale in migraine: The outcomes and implications of the MIST trial</title><description>The relationship between patent foramen ovale (PFO) and migraine is discussed in the light of the recent Migraine Intervention with Starflex Tiral (MIST) results. This Key Opinion was presented by Professor MD Ferrari, Dr. H Koppen, and Dr. GM Terwindt, of the Leiden University Medical Centre, Leiden, The Netherlands.
</description><pubDate>2007-04-23</pubDate><link>http://www.incirculation.net/52693_87270.aspx</link></item><item><title>Are the results of clinical trials a reliable guide for your practice?</title><description>Professor Desmond Julian discusses whether results from clinical trials can be applied directly to the general patient population, and whether potential differences between trial participants and the general patient population should be considered when writing the guidelines.
</description><pubDate>2007-03-16</pubDate><link>http://www.incirculation.net/52693_86003.aspx</link></item><item><title>The INTERHEART Study: Identifying risk factors associated with first acute myocardial infarction</title><description>Professor Lars Wilhelmsen, of Göteborg University, Göteborg, Sweden, discusses the implications of the INTERHEART study, and the subsequent analyses.</description><pubDate>2007-03-13</pubDate><link>http://www.incirculation.net/52693_85825.aspx</link></item><item><title>The abolition of acute myocardial infarction as a major killer</title><description>Professor Annika Rosengren, of the Sahlgrenska University Hospital, Göteborg, Sweden, provides a comprehensive editorial that discusses the abolition of acute myocardial infarction as a global major killer.</description><pubDate>2007-03-13</pubDate><link>http://www.incirculation.net/52693_85831.aspx</link></item><item><title>Acupuncture in cardiology</title><description>Professor Tsung O. Cheng, M.D, from The George Washington University, Washington D.C., USA, provides a fascinating overview of the use of acupuncture in cardiology. This editorial is extensively referenced with a comprehensive list of further reading.
</description><pubDate>2007-02-07</pubDate><link>http://www.incirculation.net/52693_84432.aspx</link></item></channel></rss>